The new program will launch extensive educational campaigns to raise awareness of eczema and fungal infections, while providing practical resources and tools that help patients and their families understand and manage the disease with awareness and confidence.
What does this agreement mean for the Iraqi patient?
• Simplified and easily accessible information: instruction manuals, educational stories, magazines and coloring books for children to support patients and their families.
• Direct support in schools and the community: field campaigns targeting children and students to create a more eczema-conscious generation.
• Enhancing the role of physicians: providing medical staff with the latest scientific developments to help patients receive the best care.
• Supportive Patient Environment: Community initiatives to enable the patient and their family to share experiences, breaking the silence about skin diseases.
In her speech at the signing ceremony, Dr. Hadaf Al-Junai, President of the Iraqi Society of Dermatology, said: "Our first goal is the Iraqi patient. This agreement gives him the knowledge and ability to face his illness, and opens the door to a more comfortable and healthy life."
Samer Lazik, General Manager for the Gulf, Levant and Export Countries at Jamjoom Pharma, said: "At Jamjoom Pharma, we believe that change starts with the patient himself. Through ECZPLORE, we will provide him with the tools he needs to become an effective partner in his treatment journey."
The agreement will last for two years, during which a series of activities, campaigns and educational programs will be launched in various cities of Iraq, with the aim of bringing medical knowledge closer to every patient and his family.
No comments:
Post a Comment